{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:42:20Z","timestamp":1790836940479,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11652"],"award-info":[{"award-number":["JP24K11652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JST CREST","award":["JPMJCR18S4"],"award-info":[{"award-number":["JPMJCR18S4"]}]},{"DOI":"10.13039\/501100019770","name":"Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences","doi-asserted-by":"publisher","award":["No.21-101"],"award-info":[{"award-number":["No.21-101"]}],"id":[{"id":"10.13039\/501100019770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21am0101124, JP24ama121046, JP24gm1610006, JP24gm0010010, JP23am0401002, JP24gm1810008"],"award-info":[{"award-number":["JP21am0101124, JP24ama121046, JP24gm1610006, JP24gm0010010, JP23am0401002, JP24gm1810008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73770-5","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:02:03Z","timestamp":1728043323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Developing a workflow for the isolation of hybridoma cells producing fully human antigen-specific antibodies using a surface IgG detection method"],"prefix":"10.1038","volume":"14","author":[{"given":"Hiroyuki","family":"Satofuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Oshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kazuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"73770_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler, G. & Milstein, C. Cultivos continuos de c\u00e9lulas fusionadas que secretan anticuerpos de especificidad predefinida. Nature256, 495\u2013497 (1975).","journal-title":"Nature"},{"key":"73770_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-022-00098-9","volume":"3","author":"Y Tian","year":"2022","unstructured":"Tian, Y., Hu, D., Li, Y. & Yang, L. Development of therapeutic vaccines for the treatment of diseases. Mol. Biomed.3, 1\u201330 (2022).","journal-title":"Mol. Biomed."},{"key":"73770_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00005-014-0322-x","volume":"63","author":"M Br\u00fcggemann","year":"2015","unstructured":"Br\u00fcggemann, M. et al. Human antibody production in transgenic animals. Arch Immunol Ther Exp (Warsz)63, 101\u2013108 (2015).","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"73770_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nbt1135","volume":"23","author":"N Lonberg","year":"2005","unstructured":"Lonberg, N. Human antibodies from transgenic animals. Nat Biotechnol23, 1117\u20131125 (2005).","journal-title":"Nat Biotechnol"},{"key":"73770_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nbt.2825","volume":"32","author":"EC Lee","year":"2014","unstructured":"Lee, E. C. et al. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat Biotechnol32, 356\u2013363 (2014).","journal-title":"Nat Biotechnol"},{"key":"73770_CR6","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1073\/pnas.1324022111","volume":"111","author":"AJ Murphy","year":"2014","unstructured":"Murphy, A. J. et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc. Nat. Acad. Sci.111, 5153\u20135158 (2014).","journal-title":"Proc. Nat. Acad. Sci."},{"key":"73770_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-29421-2","volume":"13","author":"H Satofuka","year":"2022","unstructured":"Satofuka, H. et al. Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci. Nat Commun13, 1\u201315 (2022).","journal-title":"Nat Commun"},{"key":"73770_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31263-x","author":"H Satofuka","year":"2023","unstructured":"Satofuka, H. et al. Characterization of human anti - EpCAM antibodies for developing an antibody-drug conjugate. Sci. Rep.https:\/\/doi.org\/10.1038\/s41598-023-31263-x (2023).","journal-title":"Sci. Rep."},{"key":"73770_CR9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/mt.2015.148","volume":"23","author":"F Fusil","year":"2015","unstructured":"Fusil, F. et al. A lentiviral vector allowing physiologically regulated membrane-anchored and secreted antibody expression depending on B-cell maturation status. Mol. Therapy23, 1734\u20131747 (2015).","journal-title":"Mol. Therapy"},{"issue":"369","key":"73770_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"1979","author":"PJM Brouwer","year":"2020","unstructured":"Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science1979(369), 643\u2013650 (2020).","journal-title":"Science"},{"key":"73770_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","volume":"584","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature584, 450\u2013456 (2020).","journal-title":"Nature"},{"issue":"369","key":"73770_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"1979","author":"J Hansen","year":"2020","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science1979(369), 1010\u20131014 (2020).","journal-title":"Science"},{"key":"73770_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell182, 73\u201384 (2020).","journal-title":"Cell"},{"key":"73770_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41587-021-00894-8","volume":"39","author":"SM Keating","year":"2021","unstructured":"Keating, S. M. et al. Generation of recombinant hyperimmune globulins from diverse B-cell repertoires. Nat. Biotechnol.39, 989\u2013999 (2021).","journal-title":"Nat. Biotechnol."},{"key":"73770_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.it.2021.10.008","volume":"42","author":"A Pedrioli","year":"2021","unstructured":"Pedrioli, A. & Oxenius, A. Single B cell technologies for monoclonal antibody discovery. Trends Immunol.42, 1143\u20131158 (2021).","journal-title":"Trends Immunol."},{"key":"73770_CR16","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.immuni.2021.08.025","volume":"54","author":"T Onodera","year":"2021","unstructured":"Onodera, T. et al. A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site. Immunity54, 2385\u20132398 (2021).","journal-title":"Immunity"},{"key":"73770_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol20, 229\u2013238 (2020).","journal-title":"Nat Rev Immunol"},{"key":"73770_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ncomms1475","volume":"2","author":"T Nojima","year":"2011","unstructured":"Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat. Commun.2, 465 (2011).","journal-title":"Nat. Commun."},{"key":"73770_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3460","volume":"17","author":"R Shinnakasu","year":"2016","unstructured":"Shinnakasu, R. et al. Regulated selection of germinal-center cells into the memory B cell compartment. Nat. Immunol.17, 861\u2013869 (2016).","journal-title":"Nat. Immunol."},{"key":"73770_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jbiosc.2017.10.012","volume":"125","author":"S Akagi","year":"2018","unstructured":"Akagi, S., Nakajima, C., Tanaka, Y. & Kurihara, Y. Flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody. J. Biosci. Bioeng.125, 464\u2013469 (2018).","journal-title":"J. Biosci. Bioeng."},{"key":"73770_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.889372","volume":"13","author":"BD Wines","year":"2022","unstructured":"Wines, B. D. et al. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Front. Immunol.13, 1\u201315 (2022).","journal-title":"Front. Immunol."},{"key":"73770_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0090-1229(89)90125-6","volume":"50","author":"SL Brown","year":"1989","unstructured":"Brown, S. L. & Morrison, S. L. Regulation of the production of secretory and membrane immunoglobulin during lymphocyte development. Clin. Immunol. Immunopathol.50, 155\u2013170 (1989).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"73770_CR23","first-page":"ea0116","volume":"2","author":"P Liew","year":"2012","unstructured":"Liew, P. The longevity of the humoral immune response\u2014survival of long-lived plasma cells. Akademeia2, ea0116 (2012).","journal-title":"Akademeia"},{"key":"73770_CR24","doi-asserted-by":"publisher","first-page":"E1888","DOI":"10.1073\/pnas.1422490112","volume":"112","author":"X Chang","year":"2015","unstructured":"Chang, X., Li, B. & Rao, A. RNA-binding protein hnRNPLL regulates mRNA splicing and stability during B-cell to plasma-cell differentiation. Proc. Natl. Acad. Sci. USA112, E1888\u2013E1897 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"73770_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/eji.201747019","volume":"47","author":"K Pracht","year":"2017","unstructured":"Pracht, K. et al. A new staining protocol for detection of murine antibody-secreting plasma cell subsets by flow cytometry. Eur. J. Immunol.47, 1389\u20131392 (2017).","journal-title":"Eur. J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73770-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:04:40Z","timestamp":1728043480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73770"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73770-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3993293\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and H.Tanaka, K.H., K.M., and H. Takayama are employees of Trans Chromosomics, Inc. S.I. is a CEO, employee, and shareholder of Purotech Bio Inc. The remaining authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23138"}}